摘要
免疫耐受可通过各种方法诱导。这篇综述的目的在于描述两种独特的免疫耐受模型,即前房相关免疫偏离 (ACAID)和镍诱导口服耐受的相似性与对比度。 ACAID是一种免疫耐受模型,再注射抗原进入眼睛的前房后能导致外围产生CD4+ T调节细胞和CD8+ T调节细胞。镍诱导口服耐受是另外一种免疫耐受模型,由接触过敏源镍诱导,在口腔接触后导致镍特异性CD4+ CD25+ T调节细胞产生。不同免疫耐受模型的目的是确定哪些模型是普遍的哪些机制是用于特定模型的。对这些机制的了解能帮助科学家和研究人员对不同的免疫降低模式进行更好的介入。
关键词: 耐受,ACAID,镍,口服耐受,调控T细胞,细胞活素。
Current Molecular Medicine
Title:Immune Tolerance Elicited via Unique Ocular and Oral Routes
Volume: 15 Issue: 1
Author(s): H.M. Ashour
Affiliation:
关键词: 耐受,ACAID,镍,口服耐受,调控T细胞,细胞活素。
摘要: Immune tolerance can be induced by numerous methods. This review article aims to draw lines of similarity and contrast between two unique models of immune tolerance, namely Anterior Chamber Associated Immune Deviation (ACAID) and Nickel-induced oral tolerance. ACAID is an immune tolerance model that leads to the generation of CD4+ T regulatory cells and CD8+ T regulatory cells in the periphery after the injection of an antigen into the anterior chamber of the eye. Nickel-induced oral tolerance is another immune tolerance model that is induced by the contact allergen Nickel and leads to the generation of Nickel-specific CD4+ CD25+ T regulatory cells after oral exposure. The goal of comparing different models of immune tolerance is to identify which mechanisms are universal and which mechanisms are model-specific. The knowledge of such mechanisms would allow scientists and clinicians to better intervene in different immune deregulation scenarios.
Export Options
About this article
Cite this article as:
H.M. Ashour , Immune Tolerance Elicited via Unique Ocular and Oral Routes, Current Molecular Medicine 2015; 15 (1) . https://dx.doi.org/10.2174/1566524015666150114114602
DOI https://dx.doi.org/10.2174/1566524015666150114114602 |
Print ISSN 1566-5240 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5666 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Xenograft models of primary acute myeloid leukemia for the development of imaging strategies and evaluation of novel targeted therapies.
Current Pharmaceutical Biotechnology Posttranslational Modifications and Subcellular Localization Signals: Indicators of Sequence Regions without Inherent 3D Structure?
Current Protein & Peptide Science Meet Our Editorial Board Member
Current Drug Targets ACKNOWLEDGEMENTS
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Molecular Targets and Angiogenesis in Renal Cell Carcinoma, A Multitarget Approach: Mini Review
Current Drug Targets Consequences of Iron Accumulation in Microglia and its Implications in Neuropathological Conditions
CNS & Neurological Disorders - Drug Targets Emerging Therapeutic Agents for Cervical Cancer
Recent Patents on Anti-Cancer Drug Discovery [1, 2, 4]-Oxadiazoles: Synthesis and Biological Applications
Mini-Reviews in Medicinal Chemistry Targeting Receptor Tyrosine Kinases Using Monoclonal Antibodies: The Most Specific Tools for Targeted-Based Cancer Therapy
Current Drug Targets New Therapies for Sepsis
Current Topics in Medicinal Chemistry Atherosclerotic Process in Seroreverter Children and Adolescents Exposed to Fetal Antiretroviral Therapy
Current HIV Research Modulating Poly (ADP-Ribose) Polymerase Activity: Potential for the Prevention and Therapy of Pathogenic Situations Involving DNA Damage and Oxidative Stress
Current Pharmaceutical Biotechnology Genome-Wide Expression Analysis in Epilepsy: A Synthetic Review
Current Topics in Medicinal Chemistry Graphical Abstracts
Current Drug Delivery Cell Therapy for Respiratory Diseases: Optimizing Cell Delivery Strategies
Current Respiratory Medicine Reviews Neuroinflammation: Microglial Activation During Sepsis
Current Neurovascular Research Nanotechnological Strategies to Improve Water Solubility of Commercially Available Drugs
Current Nanomedicine Acknowledgements to Reviewers:
Clinical Anti-Inflammatory & Anti-Allergy Drugs (Discontinued) Update on the Medical Treatment of Allergic Rhinitis
Inflammation & Allergy - Drug Targets (Discontinued) Role of Reactive Oxygen Species in Estrogen Dependant Breast Cancer Complication
Anti-Cancer Agents in Medicinal Chemistry